ANLON HEALTHCARE LIMITED (AHCL) 52 Week High Streak: Second Straight Session Near Yearly Peak
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
ANLON HEALTHCARE LIMITED 52 Week High Streak has now run for a second straight session, with the stock trading within 2% of its 52-week high and moving up 13.13% across the streak. The latest price action leaves AHCL near its yearly peak, while the latest Univest figures confirm the pattern but do not establish a company-specific catalyst for the repeated strength.
At Rs 24.65, AHCL was above the previous close of Rs 22.94 after opening at Rs 23.03 and touching a low of Rs 23.03 and a high of Rs 24.98. Turnover stood at Rs 5.73 crore, while market capitalisation was Rs 1,219.3 crore. For readers tracking ANLON HEALTHCARE LIMITED share price today, the point of interest is not a single-day move, but the fact that the stock has kept trading close to its one-year high across consecutive sessions.
ANLON HEALTHCARE LIMITED 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 24.65 |
| Previous Close | Rs 22.94 |
| Today's Move | +Rs 1.71 (+7.45%) |
| Open | Rs 23.03 |
| High | Rs 24.98 |
| Low | Rs 23.03 |
| Turnover | Rs 5.73 crore |
| Market Capitalisation | Rs 1,219.3 crore |
ANLON HEALTHCARE LIMITED (AHCL) traded at Rs 24.65 versus the previous close of Rs 22.94, a rise of 7.45%. The stock opened at Rs 23.03, reached a high of Rs 24.98 and touched a low of Rs 23.03.
AHCL’s share price today stayed firmly in the upper part of the day’s range, moving from the opening level to a high just shy of the 52-week peak. The stock added Rs 1.71, or 7.45%, versus the previous close and last traded at Rs 24.65. That keeps the ANLON HEALTHCARE LIMITED stock analysis focused on the repeated proximity to its yearly high rather than on a one-off move.
The day’s range was narrow enough to show that AHCL traded between Rs 23.03 and Rs 24.98, with the latest price positioned close to the day’s top end. Turnover of Rs 5.73 crore gives a factual read on traded value, and the market capitalisation of Rs 1,219.3 crore places the company in the current small-company bracket by size terms only, without implying anything about quality. For those searching ANLON HEALTHCARE LIMITED stock news or ANLON HEALTHCARE LIMITED share price update, the headline remains the same: the stock is keeping pace near a yearly high for the second straight session.
What the Repeated 52-Week Highs Show
That distinction matters for readers following ANLON HEALTHCARE LIMITED Consecutive 52 Week High or ANLON HEALTHCARE LIMITED Back To Back 52 Week Highs. A repeated-high pattern can be important because it shows where the price has been trading, but the data here stop short of explaining why. The stock has not been described as a new lifetime high or record high, and it should be read as a near 52-week high event rather than a fresh all-time peak.
ANLON HEALTHCARE LIMITED (AHCL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,219.3 crore |
| P/E Ratio | 42.76x |
| P/B Ratio | 4.18x |
| ROE | 18.73% |
| ROCE | 21.98% |
| EPS | Rs 0.54 |
| Book Value Per Share | Rs 5.49 |
| Dividend Yield | 0% |
ANLON HEALTHCARE LIMITED (AHCL) fundamental metrics show P/E 42.76x, P/B 4.18x, ROE 18.73%, ROCE 21.98%. These figures provide context only and are not a buy or sell signal.
ANLON HEALTHCARE LIMITED has a market capitalisation of Rs 1219.3 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 42.76x, P/B at 4.18x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.73% and ROCE of 21.98%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.54, book value per share of Rs 5.49, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.19x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 42.76x |
| Benchmark Median P/E | 28.19x |
| Benchmark Average P/E | 40.4x |
| Benchmark P/E Range | 0x to 683.5x |
| Company P/B Ratio | 4.18x |
| Benchmark Median P/B | 3x |
| Company ROE | 18.73% |
| Benchmark Median ROE | 11.69% |
| Company ROCE | 21.98% |
| Benchmark Median ROCE | 13.32% |
| Company Market Capitalisation | Rs 1,219.3 crore |
| Benchmark Median Market Cap | Rs 677.56 crore |
ANLON HEALTHCARE LIMITED (AHCL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
ANLON HEALTHCARE LIMITED (AHCL) has a P/E ratio of 42.76x, which is above the benchmark median of 28.19x, a difference of +51.68%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
ANLON HEALTHCARE LIMITED (AHCL) has a ROE of 18.73%, which is above the benchmark median of 11.69%, a difference of +60.22%. ANLON HEALTHCARE LIMITED (AHCL) has a ROCE of 21.98%, which is above the benchmark median of 13.32%, a difference of +65.02%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Lincoln Pharmaceuticals Ltd. | LINCOLN | 1,214.6 | 12.59 | 1.53 | 13.02 | 17.55 |
| Themis Medicare Ltd. | THEMISMED | 1,149.41 | 28.75 | 2.96 | 7.65 | 10.37 |
| Sigachi Industries Ltd. | SIGACHI | 1,130.3 | 44.58 | 2.13 | 14.49 | 16.42 |
| Bajaj Healthcare Ltd. | BAJAJHCARE | 1,107.75 | 48.11 | 2.03 | 4.35 | 7.04 |
| Kopran Ltd. | KOPRAN | 1,342.26 | 53.72 | 2.5 | 4.92 | 6.65 |
ANLON HEALTHCARE LIMITED (AHCL) has a P/E ratio of 42.76x compared with the displayed peer median of 44.58x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.73% compares with a peer median of 7.65% across the companies shown in the table. ROCE stood at 21.98% versus the displayed peer median of 10.37%, providing a capital-efficiency comparison. ANLON HEALTHCARE LIMITED (AHCL) has a market capitalisation of Rs 1,219.3 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching ANLON HEALTHCARE LIMITED
- AHCL has traded within 2% of its 52-week high for a second straight session.
- The stock has moved 13.13% across the streak, keeping it near its one-year high.
- Current valuation stands at P/E 42.76 and P/B 4.18.
- ROE of 18.73% and ROCE of 21.98% are above the industry medians.
- Turnover of Rs 5.73 crore and market cap of Rs 1,219.3 crore keep AHCL on the radar.
About ANLON HEALTHCARE LIMITED
ANLON HEALTHCARE LIMITED (AHCL) is part of the Pharmaceuticals & Drugs industry in the Healthcare sector. The company’s current market capitalisation is Rs 1,219.3 crore, and its price action is being tracked because it has remained close to its 52-week high for consecutive sessions. The stock’s latest set of ratios places it in a higher-valuation pocket versus the industry median, while profitability ratios remain comparatively healthy.
For investors and market watchers, the company is now a name to monitor within the broader list of 52 Week High Stocks and Stocks At One Year High Today. The recent streak is a price event first and foremost, and the latest Univest figures show a company whose share price, valuation and sector positioning are all drawing attention at the same time.
Track ANLON HEALTHCARE LIMITED on Univest
Follow ANLON HEALTHCARE LIMITED share price today, the latest AHCL NSE and AHCL BSE updates, and the ongoing ANLON HEALTHCARE LIMITED 52 Week High Streak on Univest. Use the stock page to monitor market movement, company news and the next price print as the repeated near-high pattern develops.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What does ANLON HEALTHCARE LIMITED 52 Week High Streak mean?
Ans. It means AHCL has traded within 2% of its 52-week high for consecutive sessions. In this case, the stock has now done so for a second straight session, which keeps the one-year high in focus for market watchers.
How many sessions has AHCL traded near its 52-week high?
Ans. According to the latest Univest figures, AHCL has traded within 2% of its 52-week high for two consecutive sessions. That is the key streak metric behind the current ANLON HEALTHCARE LIMITED 52 Week High Streak headline.
What is the cumulative move across the streak?
Ans. The cumulative move across the streak is 13.13%. This is the main differentiator versus a one-day breakout article because it captures the full repeated-high run rather than only the latest session’s change.
Did AHCL hit a new all-time high today?
Ans. No all-time high is being claimed here. The event described is a near 52-week high streak, which means the stock has traded close to its yearly peak, not necessarily at a lifetime high.
What do AHCL valuation ratios show?
Ans. AHCL trades at a P/E of 42.76 and P/B of 4.18. Those levels are above the industry median in the comparison set, so the stock is not cheap versus the middle of its peer group.
How do AHCL’s profitability ratios compare with peers?
Ans. AHCL’s ROE of 18.73% and ROCE of 21.98% are both above the industry medians in the latest dataset. That gives the stock a stronger profitability read than several names in the comparison group.
What should investors monitor next in AHCL?
Ans. Investors should watch whether AHCL continues to trade near its 52-week high, how the price behaves versus the previous close, and whether the valuation backdrop remains consistent with its sector peers. Those are the next factual checkpoints.
Is there a confirmed catalyst behind the repeated high pattern?
Ans. No company-specific catalyst is confirmed by the latest data. The streak confirms the price pattern, but it does not establish why the stock has stayed near its yearly high for multiple sessions.
Track ANLON HEALTHCARE LIMITED (AHCL) Share Price on Univest
Use ANLON HEALTHCARE LIMITED (AHCL) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
